Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients

被引：9

作者：

Masago, Katsuhiro ^{[1
]}

Fujita, Shiro ^{[2
]}

Kim, Young Hak ^{[1
]}

Ichikawa, Masataka ^{[1
]}

Hatachi, Yukimasa ^{[1
]}

Fukuhara, Akiko ^{[1
]}

Nagai, Hiroki ^{[1
]}

Irisa, Kaoru ^{[1
]}

Mio, Tadashi ^{[1
]}

Mishima, Michiaki ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan

[2] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan

来源：

CANCER GENETICS AND CYTOGENETICS | 2009年 / 195卷 / 02期

关键词：

TYROSINE KINASE DOMAIN; GENE-MUTATIONS; GEFITINIB TREATMENT; HIGH-FREQUENCY; RESPONSIVENESS; SENSITIVITY; FEATURES;

D O I：

10.1016/j.cancergencyto.2009.06.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：179 / 182

页数：4

共 25 条

[1] Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].

Bell, DW ;

Lynch, TJ ;

Haserlat, SM ;

Harris, PL ;

Okimoto, RA ;

Brannigan, BW ;

Sgroi, DC ;

Muir, B ;

Riemenschneider, MJ ;

Iacona, RB ;

Krebs, AD ;

Johnson, DH ;

Giaccone, G ;

Herbst, RS ;

Manegold, C ;

Fukuoka, M ;

Kris, MG ;

Baselga, J ;

Ochs, JS ;

Haber, DA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092

[2] Clinical experience with gefitinib: An update [J].

Cappuzzo, F ;

Finocchiaro, G ;

Metro, G ;

Bartolini, S ;

Magrini, E ;

Cancellieri, A ;

Trisolini, R ;

Castaldini, L ;

Tallini, G ;

Crino, L .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (01) :31-45

[3] Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer [J].

Chou, TY ;

Chiu, CH ;

Li, LH ;

Hsiao, CY ;

Tzen, CY ;

Chang, KT ;

Chen, YM ;

Perng, RP ;

Tsai, SF ;

Tsai, CM .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3750-3757

[4] Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients [J].

Cortes-Funes, H ;

Gomez, C ;

Rosell, R ;

Valero, P ;

Garcia-Giron, C ;

Velasco, A ;

Izquierdo, A ;

Diz, P ;

Camps, C ;

Castellanos, D ;

Alberola, V ;

Cardenal, F ;

Gonzalez-Larriba, JL ;

Vieitez, JM ;

Maeztu, I ;

Sanchez, JJ ;

Queralt, C ;

Mayo, C ;

Mendez, P ;

Moran, T ;

Taron, M .

ANNALS OF ONCOLOGY, 2005, 16 (07) :1081-1086

[5] Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].

Fukuoka, M ;

Yano, S ;

Giaccone, G ;

Tamura, T ;

Nakagawa, K ;

Douillard, JY ;

Nishiwaki, Y ;

Vansteenkiste, J ;

Kudoh, S ;

Rischin, D ;

Eek, R ;

Horai, T ;

Noda, K ;

Takata, I ;

Smit, E ;

Averbuch, S ;

Macleod, A ;

Feyereislova, A ;

Dong, RP ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246

[6] Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib [J].

Han, SW ;

Kim, TY ;

Hwang, PG ;

Jeong, S ;

Kim, J ;

Choi, IS ;

Oh, DY ;

Kim, LH ;

Kim, DW ;

Chung, DH ;

Im, SA ;

Kim, YT ;

Lee, JS ;

Heo, DS ;

Bang, YJ ;

Kim, NK .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2493-2501

[7] Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest Oncology Group Study [J].

Hirsch, FR ;

Varella-Garcia, M ;

McCoy, J ;

West, H ;

Xavier, AC ;

Gumerlock, P ;

Bunn, PA ;

Franklin, WA ;

Crowley, J ;

Gandara, DR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6838-6845

[8] High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan [J].

Huang, SF ;

Liu, HP ;

Li, LH ;

Ku, YC ;

Fu, YN ;

Tsai, HY ;

Chen, YT ;

Lin, YF ;

Chang, WC ;

Kuo, HP ;

Wu, YC ;

Chen, YR ;

Tsai, SF .

CLINICAL CANCER RESEARCH, 2004, 10 (24) :8195-8203

[9]

Isomura M, 2004, J CLIN ONCOL, V22, p200S

[10] Predictors of the response to gefitinib in refractory non-small cell lung cancer [J].

Kim, KS ;

Jeong, JY ;

Kim, YC ;

Na, KJ ;

Kim, YH ;

Ahn, SJ ;

Baek, SM ;

Park, CS ;

Park, CM ;

Kim, YI ;

Lim, SC ;

Park, KO .

CLINICAL CANCER RESEARCH, 2005, 11 (06) :2244-2251

← 1 2 3 →